These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11559456)

  • 41. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.
    McCaffery K; Nickel B; Moynihan R; Hersch J; Teixeira-Pinto A; Irwig L; Barratt A
    BMJ Open; 2015 Nov; 5(11):e008094. PubMed ID: 26525720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.
    Rosenberg SM; Gierisch JM; Revette AC; Lowenstein CL; Frank ES; Collyar DE; Lynch T; Thompson AM; Partridge AH; Hwang ES
    Cancer; 2022 Apr; 128(8):1676-1683. PubMed ID: 35191017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Nolthenius-Puylaert MC; van der Heijden LH; Coebergh JW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):659-63. PubMed ID: 10774294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human Ductal Carcinoma In Situ: Advances and Future Perspectives.
    Behbod F; Chen JH; Thompson A
    Cold Spring Harb Perspect Med; 2023 Oct; 13(10):. PubMed ID: 36781223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current perspectives of treatment of ductal carcinoma in situ.
    Estévez LG; Alvarez I; Seguí MÁ; Muñoz M; Margelí M; Miró C; Rubio C; Lluch A; Tusquets I
    Cancer Treat Rev; 2010 Nov; 36(7):507-17. PubMed ID: 20462701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.
    Kaplan CP; Nápoles AM; Hwang ES; Bloom J; Stewart S; Nickleach D; Karliner L
    J Womens Health (Larchmt); 2011 Feb; 20(2):215-23. PubMed ID: 21128819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of age on the breast surgery decision-making process.
    Bleicher RJ; Abrahamse P; Hawley ST; Katz SJ; Morrow M
    Ann Surg Oncol; 2008 Mar; 15(3):854-62. PubMed ID: 18058182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
    Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
    Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
    Elshof LE; Schmidt MK; Rutgers EJT; van Leeuwen FE; Wesseling J; Schaapveld M
    Ann Surg; 2018 May; 267(5):952-958. PubMed ID: 28375855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
    Joslyn SA
    Breast J; 2006; 12(1):20-7. PubMed ID: 16409583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
    Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
    Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study.
    Nickel B; McCaffery K; Houssami N; Jansen J; Saunders C; Spillane A; Rutherford C; Dixon A; Barratt A; Stuart K; Robertson G; Hersch J
    Breast; 2020 Dec; 54():99-105. PubMed ID: 32971350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ.
    Khadanga S; Lakoski SG; Hart V; Sprague BL; Ba Y; Hampton JM; Higgins ST; Ades PA; Newcomb PA; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):76-82. PubMed ID: 26545402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment decision-making in ductal carcinoma in situ: A mixed methods systematic review of women's experiences and information needs.
    Rutherford C; Mercieca-Bebber R; Butow P; Wu JL; King MT
    Patient Educ Couns; 2017 Sep; 100(9):1654-1666. PubMed ID: 28442156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term risk perceptions of women with ductal carcinoma in situ.
    Ruddy KJ; Meyer ME; Giobbie-Hurder A; Emmons KM; Weeks JC; Winer EP; Partridge AH
    Oncologist; 2013; 18(4):362-8. PubMed ID: 23568001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.